Curative Biotechnology Inc (CUBT)

[tdgnts]

I agree that it will trade thin and be subject to large moves. That also makes me believe that institutions participating in the financing intend to hold opposed to immediately sell shares as it will be difficult to sell any meaningful amount of share. This view is bolstered by the lack of warrants. That is to say, when these deals happen with warrants, the institutions can sell even at a slight loss and have a close to free ride for upside.

The fact that the company negotiated the warrants out of the agreement also leads me to believe they are confident that the price will appreciate materially and if funding is needed in the future, they can do it at a higher price than exercising the warrants at the split price.

Please also recall insiders warrants will also be subject to split adjustment with many insiders needing the price to be between $40 and $80 to have value.